TCR-T Cells in the Treatment of Advanced Pancreatic Cancer
NCT06054984
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
TCR-T Cells Injection（GB3010 Cells Injection）
Sponsor
Ruijin Hospital
Collaborators
[object Object]